Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 3, 2014, Pages

  Zhang, Jing ^a   Li, Yuan ^a   Jiang, Shujun ^a   Yu, Hao ^a   An, Wei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Augmenter of liver regeneration; ER stress; Hepatic stimulator substance; Nonalcoholic fatty liver disease; SERCA

Indexed keywords

ACETYLCYSTEINE; C EBP HOMOLOGOUS PROTEIN ANTIBODY; DYE; EUKARYOTIC INITIATION FACTOR 2ALPHA ANTIBODY; GLUCOSE REGULATED PROTEIN 78; PALMITIC ACID; PHOSPHO PRK LIKE ENDOPLASMIC RETICULUM KINASE ANTIBODY; PROTEIN ANTIBODY; REACTIVE OXYGEN METABOLITE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SCAVENGER; SODIUM DIMERCAPTOPROPANE SULFONATE; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; UNITHIOL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATIC STIMULATOR SUBSTANCE GENE; HEPATOMA CELL; LIPOTOXICITY; LIVER CELL; MITOCHONDRION; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL;

AUGMENTER OF LIVER REGENERATION; ER STRESS; HEPATIC STIMULATOR SUBSTANCE; NONALCOHOLIC FATTY LIVER DISEASE; SERCA;

ACETYLCYSTEINE; APOPTOSIS; CALCIUM; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; EIF-2 KINASE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; HEAT-SHOCK PROTEINS; HEPATOCYTES; HUMANS; LIVER; PEPTIDES; REACTIVE OXYGEN SPECIES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEINS; TRANSCRIPTION FACTOR CHOP; TRANSFECTION;

EID: 84893405239     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00117.2013     Document Type: Article

References (55)

1. Anderson N, Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60: 311-357, 2008.
2. Basseri S, Austin RC. ER stress and lipogenesis: a slippery slope toward hepatic steatosis. Dev Cell 15: 795-796, 2008.
3. Beeharry N, Chambers JA, Green IC. Fatty acid protection from palmitic acid-induced apoptosis is lost following PI3-kinase inhibition. Apoptosis 9: 599-607, 2004.
4. Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32: 235-249, 2002.
5. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340, 1997.
6. Csordas G, Hajnoczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta 1787: 1352-1362, 2009.
7. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
8. Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J Gastroenterol Hepatol 24: 443-452, 2009.
9. Farrell SR, Thorpe C. Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemistry 44: 1532-1541, 2005.
10. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443, 2003.
11. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5: 27-42, 2004.
12. Fleig WE, Hoss G. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 9: 240-248, 1989.
13. Francavilla A, Hagiya M, Porter KA, Polimeno L, Ihara I, Starzl TE. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 20: 747-757, 1994.
14. Gandhi CR. Augmenter of liver regeneration. Fibrogenesis Tissue Repair 5: 10, 2012.
15. Gatzidou E, Kouraklis G, Theocharis S. Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol 12: 4951-4958, 2006.
16. Gribilas G, Zarros A, Zira A, Giaginis C, Tsourouflis G, Liapi C, Spiliopoulou C, Theocharis SE. Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat. Dig Dis Sci 54: 2367-2376, 2009.
17. Gruol DL, Nelson TE, Hao C, Michael S, Vukojevic V, Ming Y, Terenius L. Ethanol alters opioid regulation of Ca(2+) influx through L-type Ca(2+) channels in PC12 cells. Alcohol Clin Exp Res 36: 443-456, 2012.
18. Hammadi M, Oulidi A, Gackiere F, Katsogiannou M, Slomianny C, Roudbaraki M, Dewailly E, Delcourt P, Lepage G, Lotteau S, Ducreux S, Prevarskaya N, Van Coppenolle F. Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78. FASEB J 27: 1600-1609, 2013.
19. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y, Tohyama M. Involvement of caspase-4 in endoplasmic reticulum stressinduced apoptosis and Abeta-induced cell death. J Cell Biol 165: 347-356, 2004.
20. Jiang SJ, Li W, An W. Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function. Hum Gene Ther 24: 443-456, 2013.
21. Jiang Y, Zhao M, An W. Increased hepatic apoptosis in high-fat dietinduced NASH in rats may be associated with downregulation of hepatic stimulator substance. J Mol Med (Berl) 89: 1207-1217, 2011.
22. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147: 3398-3407, 2006.
23. LaBrecque DR, Bachur NR. Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol Gastrointest Liver Physiol 242: G281-G288, 1982.
24. LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 248: 273-284, 1975.
25. Lange H, Lisowsky T, Gerber J, Muhlenhoff U, Kispal G, Lill R. An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2: 715-720, 2001.
26. 2-induced cell apoptosis. FEBS Lett 584: 3929-3935, 2010.
27. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 284: 5637-5644, 2009.
28. Liatsos GD, Mykoniatis MG, Margeli A, Liakos AA, Theocharis SE. Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS. Dig Dis Sci 48: 1929-1938, 2003.
29. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 33: 173-180, 2001.
30. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276: 14890-14895, 2001.
31. Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin resistance. Eur J Gastroenterol Hepatol 17: 823-826, 2005.
32. 2+ signaling by rat adrenal glomerulosa cells. Endocrinology 144: 4916-4922, 2003.
33. Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 28: 360-369, 2008.
34. Mei MH, An W, Zhang BH, Shao Q, Gong DZ. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 17: 638-644, 1993.
35. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004.
36. Pawlowski R, Jura J. ALR and liver regeneration. Mol Cell Biochem 288: 159-169, 2006.
37. Polimeno L, Lisowsky T, Francavilla A. From yeast to man-from mitochondria to liver regeneration: a new essential gene family. Ital J Gastroenterol Hepatol 31: 494-500, 1999.
38. Polimeno L, Rossi R, Mastrodonato M, Montagnani M, Piscitelli D, Pesetti B, De Benedictis L, Girardi B, Resta L, Napoli A, Francavilla A. Augmenter of liver regeneration, a protective factor against ROS-induced oxidative damage in muscle tissue of mitochondrial myopathy affected patients. Int J Biochem Cell Biol 45: 2410-2419, 2013.
39. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134: 568-576, 2008.
40. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 11: 372-380, 2004.
41. Shore GC, Papa FR, Oakes SA. Signaling cell death from the endoplasmic reticulum stress response. Curr Opin Cell Biol 23: 143-149, 2011.
42. Tamura S, Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 115: 1139-1142, 2005.
43. Theocharis SE, Margeli AP, Agapitos EV, Mykoniatis MG, Kittas CN, Davaris PS. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats. Scand J Gastroenterol 33: 656-663, 1998.
44. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5: 145-171, 2010.
45. Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Hereti RI, Alexandropoulou KN, Mykoniatis MG. Effect of hepatic stimulator substance (HSS) on cadmium-induced acute hepatotoxicity in the rat liver. Dig Dis Sci 49: 1019-1028, 2004.
46. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 1585: 202-212, 2002.
47. Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr 138: 1866-1871, 2008.
48. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46: 582-589, 2007.
49. Wu CK, Dailey TA, Dailey HA, Wang BC, Rose JP. The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 12: 1109-1118, 2003.
50. 2-induced cell apoptosis via preservation of mitochondria. Arch Biochem Biophys 464: 48-56, 2007.
51. Wu Y, Zhang J, Dong L, Li W, Jia J, An W. Hepatic stimulator substance mitigates hepatic cell injury through suppression of the mitochondrial permeability transition. FEBS J 277: 1297-1309, 2010.
52. 2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes. Cardiovasc Res 77: 432-441, 2008.
53. Yang Y, Jiang Y, Wang Y, An W. Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 92: 958-963, 2010.
54. Zhang M, Song G, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology 110: 1150-1155, 1996.
55. Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 18: 444-452, 2006.